Structural Genomics Consortium
In research, Structural Genomics Consortium stands highest in Life Sciences (#5,872 of 14,347 worldwide), Molecular Biology (#2,384 of 4,961 worldwide) and Biochemistry, Genetics and Molecular Biology (#3,803 of 7,814 worldwide), over all time. Relative to its size it is most specialised in Molecular Biology and Biochemistry, Genetics and Molecular Biology — Molecular Biology is 12.6× its share of world research.
- World rank, all time
- #11,905 of 42,892
- Rank in Canada
- #269 of 896
- Research works
- 290 ▼ 17% vs 2013–17
- Citations
- 17k 59.1 per fractional work
- Top-10% rate
- 33.5% record average 16.5%
- Open access
- 70% world 28%
What is Structural Genomics Consortium known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #5,872 of 14,347 | 36.8% | 190 | |
| Molecular BiologySubfield | #2,384 of 4,961 | 37.5% | 145 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,803 of 7,814 | 36.7% | 169 |
Each strip is that field’s whole ranked pool, with the notch where Structural Genomics Consortium sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Structural Genomics Consortium specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 12.6× the share of its output that it takes of world research.
- Molecular BiologySubfield · 22.8 works13×
- Biochemistry, Genetics and Molecular BiologyField · 26.0 works8.1×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.1×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 8.1×
- Pharmacology, Toxicology and Pharmaceutics 5.4×
- Chemistry 3.7×
- Immunology and Microbiology 2.3×
- Chemical Engineering 1.3×
- Materials Science 1.2×
- Medicine 1.1×
- Decision Sciences 1.0×
- Neuroscience 0.9×
- Energy 0.6×
- Physics and Astronomy 0.6×
- Computer Science 0.6×
- Engineering 0.5×
- Environmental Science 0.4×
- Veterinary 0.3×
- Agricultural and Biological Sciences 0.2×
- Arts and Humanities 0.1×
- Mathematics 0.1×
- Earth and Planetary Sciences 0.1×
- Economics, Econometrics and Finance 0.1×
- Psychology 0.1×
- Health Professions 0.1×
- Social Sciences 0.0×
Who are the top researchers at Structural Genomics Consortium?
Ranked on the composite score, Matthieu Schapira, Masoud Vedadi and Panagiotis Prinos lead among researchers whose main affiliation is Structural Genomics Consortium.
- 1 Matthieu Schapira Canada · #132,616 worldwide 296 citations · 28 works
- 2 Masoud Vedadi Canada · #164,767 worldwide 215 citations · 28 works
- 3 Panagiotis Prinos Canada · #798,875 worldwide 90 citations · 20 works
Which keywords describe research at Structural Genomics Consortium?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Transcriptional Regulation, Cancer, Epigenetic Regulation, BET Bromodomains, PROTACs, Proteasome Inhibitors and Medicinal Chemistry.
- Materials Informatics
- Parkinson's Disease
- Chemical Synthesis
- RNA methylation
- Immunity
- Immunosuppression
- Fibroblast Activation Protein
- Cancer Progression
- PET Imaging
- Oxidative Stress
- Tumor Microenvironment
- Pharmacokinetics
- Epigenetic Reprogramming
- Protein Arginine Methyltransferases
- Ubiquitin
- Cell Proliferation
- Proteasome Inhibitors
- BET Bromodomains
- Machine Learning
- Transcriptional Regulation
- Cancer Therapy
- Cancer
- Epigenetic Regulation
- PROTACs
- Medicinal Chemistry
- Proteasome
- Arginine Methylation
- DNA Methylation
- Histone Modification
- Drug Discovery
- Molecular Docking
- Virtual Screening
- Angiogenesis
- Stromal Cells
- Gene Expression
- Molecular Dynamics
- Mitochondrial Dysfunction
- m6A-seq
- Mutation
- High-Throughput
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Therapy6▲ 18×12 topics
- Transcriptional Regulation6▲ 63×4 topics
- Cancer5▲ 5.8×20 topics
- Machine Learning4▲ 2.0×9 topics
- Epigenetic Regulation3▲ 26×4 topics
- BET Bromodomains3▲ 185×1 topic
- PROTACs3▲ 185×1 topic
- Proteasome Inhibitors3▲ 67×2 topics
- Medicinal Chemistry3▲ 16×6 topics
- Cell Proliferation3▲ 51×3 topics
- Proteasome3▲ 122×1 topic
- Ubiquitin3▲ 122×1 topic
- Arginine Methylation2▲ 150×1 topic
- Protein Arginine Methyltransferases2▲ 150×1 topic
- DNA Methylation2▲ 34×3 topics
- Epigenetic Reprogramming2▲ 41×1 topic
- Histone Modification2▲ 54×1 topic
- Pharmacokinetics2▲ 15×2 topics
- Drug Discovery2▲ 16×6 topics
- Tumor Microenvironment2▲ 8.1×5 topics
- Molecular Docking2▲ 28×1 topic
- Oxidative Stress2▲ 2.1×11 topics
- Virtual Screening2▲ 38×1 topic
- PET Imaging2▲ 18×3 topics
- Angiogenesis2▲ 9.4×3 topics
- Cancer Progression2▲ 17×3 topics
- Stromal Cells2▲ 38×2 topics
- Fibroblast Activation Protein2▲ 65×1 topic
- Gene Expression2▲ 4.7×9 topics
- Immunosuppression2▲ 31×1 topic
- Molecular Dynamics2▲ 16×3 topics
- Immunity2▲ 6.0×4 topics
- Mitochondrial Dysfunction2▲ 8.8×5 topics
- RNA methylation1▲ 26×1 topic
- m6A-seq1▲ 26×1 topic
- Chemical Synthesis1▲ 24×2 topics
- Mutation1▲ 9.8×2 topics
- Parkinson's Disease1▲ 7.7×4 topics
- High-Throughput1▲ 34×1 topic
- Materials Informatics1▲ 34×1 topic
Which research topics does Structural Genomics Consortium publish most on?
By volume in 2022–2025: Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Cancer-related gene regulation and Epigenetics and DNA Methylation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Protein Degradation and Inhibitors Molecular Biology 3 works
- 2 Ubiquitin and proteasome pathways Molecular Biology 3 works
- 3 Cancer-related gene regulation Molecular Biology 2 works
- 4 Epigenetics and DNA Methylation Molecular Biology 2 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 6 Peptidase Inhibition and Analysis Oncology 2 works
- 7 RNA modifications and cancer Molecular Biology 1 works
- 8 Machine Learning in Materials Science Materials Chemistry 1 works
- 9 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 1 works
- 10 RNA and protein synthesis mechanisms Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Structural Genomics Consortium's research output changed?
Output in 2018–2022 was 17% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Toronto
- University of Toronto
- York University
- Hospital for Sick Children
- Toronto Metropolitan University
- University Health Network
- Sunnybrook Health Science Centre
- St. Michael's Hospital
- Princess Margaret Cancer Centre
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.